Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Barrett Esophagus 6Stomach Neoplasms 4Gastritis 3Zollinger-Ellison Syndrome 2Stomach Ulcer 2Peptic Ulcer 2Esophageal Neoplasms 2Dyspepsia 2Colorectal Neoplasms 2Breast Neoplasms 2Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastroesophageal Reflux 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Colonic Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Esomeprazole × Clear all
NCT03708211 2020-12-29

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
20 enrolled 23 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡